Home
About
Overview
Sharing Data
ORCID
Help
History (15)
Subcutaneous tocilizumab versus placebo in combination with disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
Treatment of systemic lupus erythematosus patients with the BAFF antagonist "peptibody" blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials.
Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus.
Repetitive Sequences, Nucleic Acid
High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin.
High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin. Arthritis Rheum. 2001 Jun; 44(6):1466-7.
View in:
PubMed
subject areas
Adult
Antiphospholipid Syndrome
Aspirin
Drug Therapy, Combination
Female
Fetal Death
Heparin
Humans
Pregnancy
Thrombosis
Treatment Outcome
authors with profiles
Joan Merrill